Quick Answer
CytoDyn Inc. reported Total Revenue of $0.00 for the year ending 2023.
- CytoDyn Inc. showed a decrease of -100.0% in Total Revenue from 2022 to 2023.
- This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on September 14, 2023.
- XBRL data for this metric is available from 2021 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $0.00 | Q3 2021: $41.0 thousand | Q3 2021: $41.0 thousand | Q4 2021: $225.0 thousand | Q4 2021: $225.0 thousand.
- Historical annual values: Fiscal year 2023: $0.00 | Fiscal year 2022: $266.0 thousand | Fiscal year 2021: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: